Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

David R. Matthews, J P Hosker, A. Rudenski et al. · Diabetologia · 1985 · 31K citations · Full text

Insulin Resistance, Obesity, Metabolic Syndrome +13

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

Paul M. Ridker, Julie E. Buring, Nancy R. Cook et al. · Circulation · 2003 · 2.3K citations

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Paul Angulo, Jill C. Keach, Kenneth P. Batts et al. · Hepatology · 1999 · 1.6K citations · Full text

Gastroenterology, Pathology, Fatty Liver Disease +17

Liver fibrosis in overweight patients

Vlad Ratziu, Philippe Giral, Frédéric Charlotte et al. · Gastroenterology · 2000 · 969 citations · Full text

Obesity, Metabolic Associated Steatohepatitis, Body Composition +11